Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BIOYF BIOSYENT INC > Company Executives
BIOYF BIOSYENT INC
5.1400.0000.00%
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. Rene C. GoehrumChairman of the Board, President and Chief Executive Officer------63male04/21/2022
Mr. Robert MarchVice President, Finance and Chief Financial Officer--------male04/21/2022
Mr. Kevin WilsonVice President, Community Health Business--------male04/21/2022
Mr. Joost van der MarkVice President, Corporate Development--------male04/21/2022
Mr. Sharan RaghubirDirector, Hospital Business Unit--------male04/21/2022
Dr. Navid Ashrafi, M.D.Director, Medical and Regulatory Affairs--------male04/21/2022
Ms. Neelu AtwalDirector, Human Resources--------female04/21/2022
Mr. Ramesh MoothanDirector, International Business Unit--------male04/21/2022
Mr. Peter D. LockhardLead Independent Director------59male04/21/2022
Mr. Larry AndrewsIndependent Director------70male04/21/2022
Mr. Stephen WiltonIndependent Director------62male04/21/2022
Ms. Sara C. ElfordIndependent Director------52female04/21/2022
Mr. Joseph ArcuriIndependent Director------57male04/21/2022
Company Overview More
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System, Tibella, Combogesic, and Cysview. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada.
CEO: Mr. Rene C. Goehrum
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist